Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMEA) Stock Price & Analysis

RMEA Stock Chart & Stats

€21.60€0.00(0.00%)
At close: 5:30 PM GMT+1
€18€19€20€2126 Feb13 Mar11 May
Day’s Range
EUR 21.60 - EUR 22.60
52-Week Range
EUR 15.30 - EUR 22.60
Previous Close
EUR 21.60
Volume
0
Average Volume (3M)
0
Market Cap
EUR 28.96B
Enterprise Value
EUR 45.29B
Total Cash (Recent Filing)
EUR 1.01B
Total Debt (Recent Filing)
EUR 608.91M
Price to Earnings (P/E)
20.9
Beta
0.44
Next Earnings
Jan 28, 2027 (Est.)
EPS Estimate
0.27
Next Dividend Ex-Date
N/A
Dividend Yield
0.89%

Bulls Say, Bears Say

Bulls Say

Recurring Revenue Model

ResMed combines upfront device sales with recurring mask and accessory replacements plus subscription software revenue. This mix supports customer retention, steadier revenue visibility, and continued monetization of the installed PAP base as patients remain on therapy.

High Profitability And Low Leverage

Strong margins and returns indicate meaningful operating efficiency and pricing or mix benefits, while very low leverage preserves financial flexibility. This combination supports reinvestment, shareholder returns, and resilience across the next several quarters.

Product And Digital Ecosystem Growth

Growth across devices, masks, and digital tools strengthens ResMed's integrated ecosystem and can improve therapy adherence and resupply demand. New products built on existing technology and connected platforms also deepen engagement with patients and providers.

Bears Say

Astral Discontinuation Headwind

Ending Astral sales removes an established life-support revenue stream and creates a structural drag on reported growth. Although management is prioritizing existing patients, the discontinuation reduces product breadth and leaves the forecast dependent on other businesses to offset it.

Recent Free Cash Flow Weakness

Lower free cash flow temporarily weakens the conversion of earnings into deployable cash and may reduce flexibility for investment or capital returns if it persists. Inventory buildup and tax prepayments also increase working-capital demands during the coming quarters.

Inflation And Expansion Cost Pressure

Rising component costs can pressure margins or require pricing actions, while the expanding manufacturing footprint adds near-term expenses before its benefits are fully realized. These forces challenge the durability of recent margin gains despite the productivity pipeline.

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh News

RMEA FAQ

What was Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price range in the past 12 months?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh lowest stock price was €15.30 and its highest was €22.60 in the past 12 months.
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap is €28.96B.
When is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s upcoming earnings report date?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s next earnings report is estimated for Jan 28, 2027 (not yet confirmed), which is in 87 days.
How were Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s earnings last quarter?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh released its earnings results on Oct 29, 2026. The company reported €0.26 earnings per share for the quarter, beating the consensus estimate of €0.239 by €0.021.
Is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh overvalued?
According to Wall Street analysts Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price is currently Undervalued.
Does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pay dividends?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh does not currently pay dividends.
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate is 0.27.
How many shares outstanding does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh have?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has 1,406,392,500 shares outstanding.
What happened to Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price movement after its last earnings report?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh reported an EPS of €0.26 in its last earnings report, beating expectations of €0.239. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh?
Currently, no hedge funds are holding shares in DE:RMEA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology